Carolina, GSK partner to seek cure for HIV

Carolina, GSK partner to seek cure for HIV (Image 1)

Two big names in research and medicine are joining forces to find a cure for HIV Aids.

UNC Chapel Hill and Glaxo-Smith Kline announced a public-private partnership to build an HIV Cure center on campus. GSK will invest $4 million a year for 5 years to pay for the initial research plan.
A small research team from GSK will move to Chapel Hill to be located with the UNC researchers.

“We look forward to seeing progress to the millions work like this,” commented Sir Andrew Witty, GSK CEO.

The focus will be on the latest scientific approaches to curing HIV, including an approach called “Shock and Kill” which is a way of trying to reveal the hidden virus that persists in people despite drug therapy.

WNCT-TV 9 On Your Side provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s